Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03419585 · ClinicalTrials.gov registry record · NA
The "PC-LIGHT" Study
A NA study of Prostate Cancer and Depression, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT03419585: Completed NA study of Prostate Cancer and Depression, sponsored by Northwestern University.
NCT03419585 is a NA study of Prostate Cancer and Depression that has completed, run by Northwestern University. The registered enrollment target is 75 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03419585, a NA study of Prostate Cancer and Depression, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
Fatigue due to cancer and its treatment (for example, radiation therapy) can interfere with quality of life and can linger long after treatment has ended, yet research examining preventative approaches has produced limited clinical benefit. The proposed study will provide information about systematic light exposure for the prevention of fatigue in prostate cancer patients undergoing radiation therapy and will investigate how it works. This study would facilitate the development of this potential preventative treatment, giving health care providers and cancer survivors a much-needed tool to help with cancer-related fatigue.
Primary Outcome
FACIT-Fatigue scores
Conditions Studied
Interventions
- DEVICE Intervention systematic light exposure
- DEVICE Comparison systematic light exposure
Study Locations (1)
Illinois
- Northwestern Univeristy Feinberg School of Medicine - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2018-12-12 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
What the finished NCT03419585 record still lists
NCT03419585 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (88% lower).
The record links to 5 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which Intervention systematic light exposure is the first listed.
NCT03419585 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT03419585 about?
NCT03419585 is a clinical study titled "The "PC-LIGHT" Study". Fatigue due to cancer and its treatment (for example, radiation therapy) can interfere with quality of life and can linger long after treatment has ended, yet research examining preventative approaches has produced limited clinical benefit. The proposed study will provide information about systemati...
What is the current status of trial NCT03419585?
This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2018-12-12. Estimated completion is 2023-12-31.
What conditions does trial NCT03419585 study?
This clinical trial studies the following conditions: Prostate Cancer, Depression, Sleep, Fatigue, Quality of Life.
What interventions are being tested in trial NCT03419585?
The interventions under investigation include: Intervention systematic light exposure (DEVICE), Comparison systematic light exposure (DEVICE).
Who is sponsoring clinical trial NCT03419585?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03419585 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03419585's enrollment target sits among peer trials
75 392nd of 735 higher than 341 of 735 other Prostate Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI